₩ 5580
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Strong margins and returns
Data is available to registered users only
Data is available to registered users only
About
Established on November 11, 2002, TDS Pharm Co. Ltd. is headquartered in Seongnam-si, South Korea, and specializes in the creation and manufacturing of transdermal drug delivery solutions. Their offerings include items such as cataplasma, plasta, fucidin band, and various prescription pharmaceuticals.
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/
Data is available to registered users only